Is a complete TPEX/6564 research report available?

No complete published report is available for tpex/6564 (TPEX/6564) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TPEX/6564 (TPEX/6564)

Taipei Exchange: TPEX/6564 · TWD

NT$15.4

-0.20 (-1.3%)· Recorded snapshot

Market cap	936M
Revenue (ttm)	53.4M
Net income (ttm)	-120.9M
EPS (ttm)	-NT$1.68
Shares out	60M
Volume	10,000
Beta	0.26

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 53.4M
Net income (ttm): -120.9M
EPS (ttm): -NT$1.68
Market cap: 936M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

All TPEX/6564 indicators

Market & fundamental data

Available fields

184

Groups with data

Currency

TWD

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	38
Employees Change	9%
Employees Change Percent	31.03
Enterprise value	TWD 553.7M
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Industry PE Fwd	32.87
Isin	TW0006564008
Last refreshed	2026-09-08
Market cap	TWD 936M
Price	TWD 15.4
Price currency	TWD
Sector	Healthcare
Sector PE	88.9
Sector PE Fwd	27.78
Sic	2836
Symbol	tpex/6564
Website	https://www.enimmune.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-12.91%
EV/Sales	10.36x
FCF yield	-9.21%
P/B ratio	9.32x
P/S ratio	17.51x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-232.49%
EBITDA Margin	-220.33%
Gross margin	8.06%
Gross Profit	TWD 4.3M
Gross Profit Growth	-69.62%
Gross Profit Growth Q	-46.06%
Gross Profit Growth3 Y	-37.18%
Gross Profit Growth5 Y	-32.14%
Net Income	TWD -120.9M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-226.16%
Profit Margin	-226.16%
ROA	-16.87
Roa5y	-17.51
ROCE	-91.11
ROE	-74.45
Roe5y	-36.65
ROIC	-23.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-25.32%
Cagr3y	-27.66%
Cagr5y	-19.59%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth	26.56x
Revenue Growth Q	23.21x
Revenue Growth Qo Q	9.19x
Revenue Growth Quarters	3x
Revenue Growth Years	1x
Revenue Growth3 Y	-21.22x
Revenue Growth5 Y	-6.07x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.12
Assets	TWD 399.6M
Cash	TWD 172.4M
Current Assets	TWD 267M
Current Liabilities	TWD 263.2M
Debt	TWD 159.6M
Debt Equity	TWD 1.59
Debt FCF	TWD -1.85
Equity	TWD 100.4M
Interest Coverage	-27.71
Liabilities	TWD 299.2M
Long Term Assets	TWD 132.7M
Long Term Liabilities	TWD 36M
Net Cash	TWD 12.9M
Net Cash By Market Cap	TWD 1.38
Net Cash Growth	-87.14%
Net Debt Equity	TWD -0.13
Tangible Book Value	TWD 3.8M
Tangible Book Value Per Share	TWD 0.05
WACC	5.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.01
Inventory Turnover	1.6
Net Working Capital	TWD -45.1M
Quick ratio	0.83
Working Capital	TWD 3.7M
Working Capital Turnover	TWD 0.95

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.64%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-25.3%
200-day SMA	18.37
3Y total return	-62.16%
50-day SMA	16.32
50-day SMA vs 200-day SMA	50under200
5Y total return	-66.38%
All Time High	125
All Time High Change	-87.6%
All Time High Date	2020-07-06
All Time Low	14.49
All Time Low Change	6.97%
All Time Low Date	2020-03-19
ATR	0.65
Beta	0.26
Beta1y	0.14
Beta2y	0.27
Ch YTD	-24.76
High	15.6
High52	23.9
High52 Date	2025-10-23
High52ch	-35.56%
Low	15.4
Low52	14.9
Low52 Date	2026-07-29
Low52ch	3.36%
Ma50ch	-5.01%
Price vs 200-day SMA	-15.62%
RSI	37.72
RSI Monthly	32.3
RSI Weekly	38.23
Sharpe ratio	-0.01x
Sharpe Ratio3y	-0.73x
Sharpe Ratio5y	-0.38x
Sortino ratio	0.13
Sortino Ratio3y	-0.97
Sortino Ratio5y	-0.47
Total Return	2.64%
Tr YTD	-24.76
Tr1m	-7.74%
Tr1w	-5.78%
Tr3m	-11.17%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	30,849,978%
Net Borrowing	-8,187,000
Shares Insiders	0.89%
Shares Institutions	4.66%
Shares Out	60,000,000
Shares Qo Q	0%
Shares Yo Y	-2.64%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -86.8M
Adjusted OCF	-84,064,000
Average Volume	47,921.25x
Bv Per Share	1.39
CAPEX	TWD -2.7M
Ch1m	-7.74
Ch1w	-5.78
Ch1y	-25.3
Ch3m	-11.17
Ch3y	-62.2
Ch5y	-66.41
Ch6m	-11.93
Change	-1.28%
Change From Open	-0.32
Close	15.6
Days Gap	-0.96
Depreciation Amortization	6,500,000
Dollar Volume	154,000
Earnings Date	2026-11-12
EBIT	TWD -124.3M
EBITDA	TWD -117.8M
EPS	TWD -1.68
F Score	2
FCF	TWD -86.2M
FCF EV Yield	-15.57x
FCF Per Share	TWD -1.44
Financing CF	-8,187,000
Fiscal Year End	December
Founded	2,014
Investing CF	12,279,000
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2026-06-30
Ma150	17.67
Ma150ch	-12.26%
Ma20	16.37
Ma20ch	-5.33%
Net CF	-83,055,000
Next Earnings Date	2026-11-12
Open	15.45
Position In Range	0
Ppne	11,594,000
Price Date	2026-09-08
Ptbv Ratio	246.2
Relative Volume	0.21x
Revenue	53,449,000x
SBC By Revenue	1.16x
Share Based Comp	619,000
Tr6m	-11.93%
Volume	10,000
Z Score	-0.38

TPEX/6564 (TPEX/6564)

Price

Financial snapshot

Fair-value bridge

Latest news · TPEX/6564

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TPEX/6564 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on TPEX/6564

Frequently asked questions